Twenty-Four-Month Results of Intravitreal Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion

被引:9
|
作者
Tsagkataki, M. [1 ]
Papathomas, T. [1 ]
Lythgoe, D. [2 ]
Kamal, A. [1 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Dept Ophthalmol, Liverpool L9 7AL, Merseyside, England
[2] Liverpool CR UK Ctr, Liverpool, Merseyside, England
关键词
Avastin; macular oedema; retinal ischaemia; visual acuity; vein occlusion; THERAPY; INJECTION; AVASTIN(R); CYTOKINES;
D O I
10.3109/08820538.2013.874488
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The aim of this study is to evaluate the long-term efficacy of intravitreal bevacizumab (IVB) in macular edema (ME) due to branch retinal vein occlusion (BRVO) in a real clinical practice setting at a tertiary referral center. Methods: A retrospective analysis of a final total number of 35 eyes of 35 patients with a 24-month follow-up was performed. Results: At 24 months, mean best-corrected visual acuity improved by 0.09 LogMAR units from baseline (95% CI: -0.03-0.24, p=0.0674). The mean CFT decreased by 75 microns (95% CI: 27-123, p=0.0026). The median number of injections was 6 (IQR: 3-9). Macular edema showed complete resolution in 12 eyes (34.3%), responded partially in six eyes (17%), recurred in eight eyes (23%), and remained persistent in nine eyes (25.7%, three eyes at six months, one eye at 12 months, three eyes at 18 months and two eyes at 24 months). Conclusion: Our study shows that treatment with IVB in patients with ME due to BRVO during a period of 24 months provided complete resolution of the ME in more than one-third of patients. In one-third of the cases, ME resolved partially or recurred and in less than one-third of patients ME remained persistent. Visual acuity increased significantly in 23% of patients and remained stable in the majority of patients. However, a median number of six injections was necessary to maintain a lasting beneficial effect. Further long-term prospective studies are required comparing intravitreal bevacizumab with other treatment modalities.
引用
收藏
页码:352 / 359
页数:8
相关论文
共 50 条
  • [41] Intravitreal Pegaptanib Sodium for Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
    Udaondo, P.
    Garcia-Delpech, S.
    Salom, D.
    Bosch, F.
    Diaz-Llopis, M.
    PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, : 193 - +
  • [42] Intravitreal Plasmin Without Vitrectomy for Macular Edema Secondary to Branch Retinal Vein Occlusion
    Udaondo, Patricia
    Diaz-Llopis, Manuel
    Garcia-Delpech, Salvador
    Salom, David
    Romero, Francisco J.
    ARCHIVES OF OPHTHALMOLOGY, 2011, 129 (03) : 283 - 287
  • [43] PREDICTORS OF REFRACTORY MACULAR EDEMA AFTER BRANCH RETINAL VEIN OCCLUSION FOLLOWING INTRAVITREAL BEVACIZUMAB
    Moon, Byung Gil
    Cho, Ah Ran
    Kim, You Na
    Kim, June-Gone
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (06): : 1166 - 1174
  • [44] Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion
    Çekiç, O
    Chang, S
    Tseng, JJ
    Barile, GR
    Del Priore, LV
    Weissman, H
    Schiff, WM
    Ober, MD
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (07): : 851 - 855
  • [45] Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review
    Yilmaz, Taygan
    Cordero-Coma, Miguel
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (06) : 787 - 793
  • [46] Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review
    Taygan Yilmaz
    Miguel Cordero-Coma
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2012, 250 : 787 - 793
  • [47] Intravttreal bevacizumab (avastin) in the treatment of macular edema secondary to branch retinal vein occlusion
    Rabena, Melvin D.
    Pieramici, Dante J.
    Castellarin, Alessandro A.
    Nasir, Ma'an A.
    Avery, Robert L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04): : 419 - 425
  • [48] COMPARISON OF INTRAVITREAL BEVACIZUMAB AND TRIAMCINOLONE ACETONIDE WITH INTRAVITREAL BEVACIZUMAB ALONE IN MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
    Attique, Usman
    Mahsood, Yousaf Jamal
    Jan, Sanaullah
    KHYBER MEDICAL UNIVERSITY JOURNAL-KMUJ, 2021, 13 (01): : 15 - 19
  • [49] Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion: 12-month results
    Nishimura, Tomoharu
    Machida, Shigeki
    Tada, Atsushi
    Oshida, Eiki
    Muto, Tetsuya
    DOCUMENTA OPHTHALMOLOGICA, 2020, 141 (02) : 127 - 136
  • [50] Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion: 12-month results
    Tomoharu Nishimura
    Shigeki Machida
    Atsushi Tada
    Eiki Oshida
    Tetsuya Muto
    Documenta Ophthalmologica, 2020, 141 : 127 - 136